Rivastigmine for the treatment of dementia associated with Alzheimer's disease or Parkinson's disease
Agency for Care Effectiveness (ACE)
Record ID 32018002523
English
Details
Project Status:
Completed
Year Published:
2018
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/details/rivastigmine-for-the-treatment-of-dementia-associated-with-alzheimer's-disease-or-parkinson's-disease
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Dementia
- Alzheimer Disease
- Parkinson Disease
- Rivastigmine
- Cholinesterase Inhibitors
- Neuroprotective Agents
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.